Hepatitis C virus infection and incident type 2 diabetes

被引:336
作者
Mehta, SH
Brancati, FL
Strathdee, SA
Pankow, JS
Netski, D
Coresh, J
Szklo, M
Thomas, DL
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[2] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
关键词
D O I
10.1053/jhep.2003.50291
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although hepatitis C virus (HCV) infection is more common among adults with type 2 diabetes, it is uncertain whether HCV precedes the development of diabetes. Thus, we performed a prospective (case-cohort) analysis to examine if persons who acquired type 2 diabetes were more likely to have had antecedent HCV infection when enrolled in a community-based cohort of men and women between the ages of 44 and 65 in the United States (Atherosclerosis Risk in Communities Study [ARIC]). Among 1,084 adults free of diabetes at baseline, 548 developed diabetes over 9 years of follow-up evaluation. Incident cases of diabetes were identified by using fasting glucose and medical history and HCV antibodies were assessed at baseline. A priori, persons were categorized as low-risk or high-risk for diabetes based on their age and body mass index, factors that appeared to modify the type 2 diabetes-HCV infection incidence estimates. The overall prevalence of HCV in this population was 0.8%. Among those at high risk for diabetes, persons with HCV infection were more than 11 times as likely as those without HCV infection to develop diabetes (relative hazard, 11.58; 95% confidence interval, 1.39-96.6). Among those at low risk, no increased incidence of diabetes was detected among HCV-infected persons (relative hazard, 0.48; 95% confidence interval, 0.05-4.40). In conclusion, pre-existing HCV infection may increase the risk for type 2 diabetes in persons with recognized diabetes risk factors. Additional larger prospective evaluations are needed to confirm these preliminary findings.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 31 条
[1]   EVIDENCE FOR A LINK BETWEEN HEPATITIS-C VIRUS-INFECTION AND DIABETES-MELLITUS IN A CIRRHOTIC POPULATION [J].
ALLISON, MED ;
WREGHITT, T ;
PALMER, CR ;
ALEXANDER, GJM .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1135-1139
[2]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[3]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[4]   ROBUST VARIANCE-ESTIMATION FOR THE CASE-COHORT DESIGN [J].
BARLOW, WE .
BIOMETRICS, 1994, 50 (04) :1064-1072
[5]   Analysis of case-cohort designs [J].
Barlow, WE ;
Ichikawa, L ;
Rosner, D ;
Izumi, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (12) :1165-1172
[6]   Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication [J].
Bouvier-Alias, M ;
Patel, K ;
Dahari, H ;
Beaucourt, S ;
Larderie, P ;
Blatt, L ;
Hezode, C ;
Picchio, G ;
Dhumeaux, D ;
Neumann, AU ;
McHutchison, JG ;
Pawlotsky, JM .
HEPATOLOGY, 2002, 36 (01) :211-218
[7]   Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection [J].
Caronia, S ;
Taylor, K ;
Pagliaro, L ;
Carr, C ;
Palazzo, U ;
Petrik, J ;
O'Rahilly, S ;
Shore, S ;
Tom, BDM ;
Alexander, GJM .
HEPATOLOGY, 1999, 30 (04) :1059-1063
[8]   A prospective study at coronary heart disease in relation to fasting insulin, glucose, and diabetes - The atherosclerosis risk in communities (ARIC) study [J].
Folsom, AR ;
Szklo, M ;
Stevens, J ;
Liao, FZ ;
Smith, R ;
Eckfeldt, JH .
DIABETES CARE, 1997, 20 (06) :935-942
[9]  
Fraser GM, 1996, ISRAEL J MED SCI, V32, P526
[10]  
Fujie H, 1999, J MED VIROL, V59, P141, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt